Skip to main content
TipRanks
Go Ultimate75% OFF

SK Biopharmaceuticals Co., Ltd. (326030) Revenue

SK Biopharmaceuticals Co., Ltd. Revenue

SK Biopharmaceuticals Co., Ltd. had a revenue of 247.37B in the quarter ending Jun 30, 2026, with 8.55%. This bring the company's revenue in the last twelve months to 861.34B, Increased 9.00%. In the fiscal year ending Dec 31, 2025, SK Biopharmaceuticals Co., Ltd. had annual revenue of 706.74B with 29.06% growth.

Revenue (ttm)
861.34B
Revenue Growth
37.40%
P/S Ratio
9.86
Revenue/Employee
KRW 2,932,535,104
Employees
241
Market Cap
KRW 6.97T

Revenue Chart

SK Biopharmaceuticals Co., Ltd. Revenue - Annual

0200B400B600B800B85.32B1.10B123.85B26.00B418.64B246.18B354.89B547.60B706.74B201720182019202020212022202320242025
Revenue History
Download to Excel
KR:326030 revenue history
Fiscal End DateRevenueChangeGrowth
Dec 31, 2025706.74B159.14B29.06%
Dec 31, 2024547.60B192.70B54.30%
Dec 31, 2023354.89B108.71B44.16%
Dec 31, 2022246.18B-172.47B-41.20%
Dec 31, 2021418.64B392.65B1510.23%
Dec 31, 202026.00B-97.85B-79.01%
Dec 31, 2019123.85B122.75B11172.24%
Dec 31, 20181.10B-84.22B-98.71%
Dec 31, 201785.32B――
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Related stocks
CompanyRevenue
KR:326030861.34B
KR:005690147.26B
KR:01100018.01B
KR:064550298.51B
KR:302440690.95B
KR:95021026.06B